Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Drug Interaction Study to Investigate the Effects of Steady State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Volunteers

NCT00960570 is registered in ClinicalTrials.gov with Mutual Pharmaceutical Company, Inc. as lead sponsor.

NCT NCT00960570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00960570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Drug Interaction Study to Investigate the Effects of Steady State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Volunteers
Lead sponsor
Mutual Pharmaceutical Company, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
March 31, 2008
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy